Procedure Volume Patient Data Patient Conditions Reviews General Payments Back to Top

Home > MI Providers

Dr. Matthew Burns Cotant, MD

Accepting New Patients

(No ratings)

Specializes in: Medical Oncology, Adult Oncology and Adult Hematology

Wayne State University School of Medicine

Professional interests include: cancer, blood disorders

3577 W 13 Mile Road Suite 103
Royal Oak, MI 48073

(248) 288-4500

Dr. Matthew Burns Cotant, MD is a medical oncologist in Royal Oak, MI specializing in medical oncology, adult oncology and adult hematology. He graduated from Wayne State University School of Medicine. Dr. Matthew Burns Cotant, MD is affiliated with Trinity Health, McLaren Health Care and Michigan Healthcare Professionals.

Office Locations

Michigan Healthcare Professionals

3577 W 13 Mile Road Suite 103
Royal Oak, MI 48073

(248) 288-4500

(248) 288-0450

open_in_new

Michigan Healthcare Professionals

4550 Investment Drive Suite B120
Troy, MI 48098

(248) 267-6569

(248) 267-6852

open_in_new

6770 Dixie Highway Suite 106-a
Clarkston, MI 48346

open_in_new

Noteworthy Medicare Patient Procedures Performed by Dr. Matthew Burns Cotant, MD in 2023

Click on any procedure below to see further details on volume and pricing among Medicare patients.

Top 5%

By Volume:

blood draw

phlebotomy for lab tests

By Affordability:

liver panel

magnesium test

phosphorus blood test

phosphorus test

uric acid blood test

uric acid test

In 2023, among providers in related specialties within Michigan, Dr. Matthew Burns Cotant, MD performed more blood draw, and phlebotomy for lab tests procedures for Medicare patients than 95% of them and he also had a list price for liver panel, magnesium test, phosphorus blood test, phosphorus test, uric acid blood test, and uric acid test that was lower than the list prices billed to Medicare by 95% of them. Actual amounts paid by patients can vary widely depending on a number of factors, including insurance coverage. A lower list price, however, might mean lower fees when paying without insurance.

Top 10%

By Volume:

complete blood count

lab tests

By Affordability:

blood tests

lab tests

In 2023, among providers in related specialties within Michigan, Dr. Matthew Burns Cotant, MD performed more complete blood count (CBC), and lab tests procedures for Medicare patients than 90% of them and he also had a list price for blood tests, and lab tests that was lower than the list prices billed to Medicare by 90% of them. Actual amounts paid by patients can vary widely depending on a number of factors, including insurance coverage. A lower list price, however, might mean lower fees when paying without insurance.

Top 25%

By Volume:

biological response modifier therapy

inpatient hospital care

intravenous chemotherapy

intravenous infusion

phosphorus blood test

uric acid blood test

By Affordability:

antineoplastic hormone therapy

hormone therapy

intravenous infusion therapy

intravenous infusion

lactate dehydrogenase test

metabolic panel

In 2012, among providers in related specialties within Michigan, Dr. Matthew Burns Cotant, MD performed more biological response modifier (BRM) therapy, inpatient hospital care (for patient admitted to hospital), intravenous (IV) chemotherapy, intravenous (IV) infusion, phosphorus blood test, and uric acid blood test procedures for Medicare patients than 75% of them and he also had a list price for antineoplastic hormone therapy, hormone therapy, intravenous infusion therapy, intravenous (IV) infusion, lactate dehydrogenase (LDH) test, and metabolic panel that was lower than the list prices billed to Medicare by 75% of them. Actual amounts paid by patients can vary widely depending on a number of factors, including insurance coverage. A lower list price, however, might mean lower fees when paying without insurance.

Medicare Procedure and Patient Information

2012 Medicare Procedure Volume

The top procedures that Dr. Matthew Burns Cotant, MD treated as a medical oncologist in Royal Oak, MI during 2012 were lab tests, blood draw, hospital care and inpatient care.

Volume of procedures performed by Dr. Matthew Burns Cotant, MD for Medicare patients.

biological response modifier (BRM) therapy	214
blood draw	1253
chemotherapy	214
doctor visit	1219
hospital care	507
inpatient care	507
lab tests	3399
minimally invasive procedures	298

Medicare Procedure and Patient Information

2013 Medicare Procedure Volume

The top procedures that Dr. Matthew Burns Cotant, MD treated as a medical oncologist in Royal Oak, MI during 2013 were lab tests, blood draw, hospital care and inpatient care.

Volume of procedures performed by Dr. Matthew Burns Cotant, MD for Medicare patients.

biological response modifier (BRM) therapy	323
blood draw	1413
chemotherapy	323
doctor visit	1395
hospital care	533
inpatient care	533
lab tests	3816
minimally invasive procedures	424

2013 Medicare Patient Data

Information about Medicare patients treated by Dr. Matthew Burns Cotant, MD.

**Gender**
Male	294
Female	398

**Ethnicity**
Non-Hispanic White	595
Black	74
Hispanic	0
Asian	0
Other	11
Native American	0

**Age**
From 65 to 74	248
From 75 to 84	272
85 and over	120
Less than 65	52

Conditions of Medicare patients treated by Dr. Matthew Burns Cotant, MD in 2013

Hypertension	75
High Cholesterol	54
Stroke	7
Ischemic Heart Disease	52
Depression	21
Chronic Kidney Disease	39
Asthma	11
Osteoperosis	12
Atrial Fibrilation	18
Heart Failure	32
Chronic Obstructive Pulmonary Disease	22
Diabetes	37
Dementia	11
Cancer	42

Medicare Procedure and Patient Information

2014 Medicare Procedure Volume

The top procedures that Dr. Matthew Burns Cotant, MD treated as a medical oncologist in Royal Oak, MI during 2014 were lab tests, blood draw, hospital care and inpatient care.

Volume of procedures performed by Dr. Matthew Burns Cotant, MD for Medicare patients.

biological response modifier (BRM) therapy	355
blood draw	1446
chemotherapy	355
doctor visit	1494
hospital care	657
inpatient care	657
lab tests	2450
minimally invasive procedures	429
preventive care	23
vaccines	23

2014 Medicare Patient Data

Information about Medicare patients treated by Dr. Matthew Burns Cotant, MD.

**Gender**
Male	327
Female	448

**Ethnicity**
Non-Hispanic White	669
Black	82
Hispanic	0
Asian	0
Other	11
Native American	0

**Age**
From 65 to 74	298
From 75 to 84	270
85 and over	138
Less than 65	69

Conditions of Medicare patients treated by Dr. Matthew Burns Cotant, MD in 2014

Hypertension	74
High Cholesterol	56
Stroke	7
Ischemic Heart Disease	49
Depression	23
Chronic Kidney Disease	38
Asthma	11
Osteoperosis	10
Atrial Fibrilation	16
Heart Failure	28
Chronic Obstructive Pulmonary Disease	21
Diabetes	36
Dementia	11
Cancer	41

Medicare Procedure and Patient Information

2015 Medicare Procedure Volume

The top procedures that Dr. Matthew Burns Cotant, MD treated as a medical oncologist in Royal Oak, MI during 2015 were lab tests, blood draw, hospital care and inpatient care.

Volume of procedures performed by Dr. Matthew Burns Cotant, MD for Medicare patients.

biological response modifier (BRM) therapy	396
blood draw	1674
chemotherapy	396
doctor visit	1648
hormone therapy	41
hospital care	658
inpatient care	658
lab tests	3541
minimally invasive procedures	496
preventive care	17
vaccines	17

2015 Medicare Patient Data

Information about Medicare patients treated by Dr. Matthew Burns Cotant, MD.

**Gender**
Male	604
Female	844

**Ethnicity**
Non-Hispanic White	1266
Black	120
Hispanic	0
Asian	0
Other	30
Native American	0

**Age**
From 65 to 74	584
From 75 to 84	504
85 and over	244
Less than 65	116

Conditions of Medicare patients treated by Dr. Matthew Burns Cotant, MD in 2015

Hypertension	75
High Cholesterol	58
Stroke	8
Ischemic Heart Disease	47
Depression	22
Chronic Kidney Disease	43
Asthma	16
Osteoperosis	10
Atrial Fibrilation	15
Heart Failure	29
Chronic Obstructive Pulmonary Disease	20
Diabetes	35
Dementia	12
Cancer	43

Medicare Procedure and Patient Information

2016 Medicare Procedure Volume

The top procedures that Dr. Matthew Burns Cotant, MD treated as a medical oncologist in Royal Oak, MI during 2016 were lab tests, blood draw, minimally invasive procedures and hospital care.

Volume of procedures performed by Dr. Matthew Burns Cotant, MD for Medicare patients.

biological response modifier (BRM) therapy	506
blood draw	1949
chemotherapy	506
doctor visit	1877
hormone therapy	56
hospital care	623
inpatient care	623
lab tests	4933
minimally invasive procedures	623
preventive care	24
vaccines	24

2016 Medicare Patient Data

Information about Medicare patients treated by Dr. Matthew Burns Cotant, MD.

**Gender**
Male	325
Female	428

**Ethnicity**
Non-Hispanic White	649
Black	72
Hispanic	0
Asian	14
Other	0
Native American	0

**Age**
From 65 to 74	304
From 75 to 84	255
85 and over	138
Less than 65	56

Conditions of Medicare patients treated by Dr. Matthew Burns Cotant, MD in 2016

Hypertension	74
High Cholesterol	59
Stroke	6
Ischemic Heart Disease	46
Depression	19
Chronic Kidney Disease	49
Asthma	26
Osteoperosis	10
Atrial Fibrilation	18
Heart Failure	29
Chronic Obstructive Pulmonary Disease	22
Diabetes	34
Dementia	13
Cancer	43

Medicare Procedure and Patient Information

2017 Medicare Procedure Volume

The top procedures that Dr. Matthew Burns Cotant, MD treated as a medical oncologist in Royal Oak, MI during 2017 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Matthew Burns Cotant, MD for Medicare patients.

biological response modifier (BRM) therapy	584
blood draw	2332
chemotherapy	584
doctor visit	2214
hormone therapy	58
hospital care	473
inpatient care	473
lab tests	5714
minimally invasive procedures	695
preventive care	40
vaccines	40

2017 Medicare Patient Data

Information about Medicare patients treated by Dr. Matthew Burns Cotant, MD.

**Gender**
Male	349
Female	462

**Ethnicity**
Non-Hispanic White	681
Black	84
Hispanic	0
Asian	0
Other	26
Native American	0

**Age**
From 65 to 74	346
From 75 to 84	266
85 and over	140
Less than 65	59

Conditions of Medicare patients treated by Dr. Matthew Burns Cotant, MD in 2017

Hypertension	72
High Cholesterol	53
Stroke	10
Ischemic Heart Disease	43
Depression	22
Chronic Kidney Disease	48
Asthma	10
Osteoperosis	14
Atrial Fibrilation	17
Heart Failure	25
Chronic Obstructive Pulmonary Disease	19
Diabetes	30
Dementia	13
Cancer	44

Medicare Procedure and Patient Information

2018 Medicare Procedure Volume

The top procedures that Dr. Matthew Burns Cotant, MD treated as a medical oncologist in Royal Oak, MI during 2018 were lab tests, blood draw, hospital care and inpatient care.

Volume of procedures performed by Dr. Matthew Burns Cotant, MD for Medicare patients.

biological response modifier (BRM) therapy	381
blood draw	1676
chemotherapy	381
doctor visit	1577
hospital care	596
inpatient care	596
lab tests	4209
minimally invasive procedures	444
preventive care	18
vaccines	18

2018 Medicare Patient Data

Information about Medicare patients treated by Dr. Matthew Burns Cotant, MD.

**Gender**
Male	281
Female	400

**Ethnicity**
Non-Hispanic White	584
Black	69
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	262
From 75 to 84	244
85 and over	116
Less than 65	59

Conditions of Medicare patients treated by Dr. Matthew Burns Cotant, MD in 2018

Hypertension	75
High Cholesterol	62
Stroke	9
Ischemic Heart Disease	44
Depression	27
Chronic Kidney Disease	55
Asthma	9
Osteoperosis	14
Atrial Fibrilation	17
Heart Failure	29
Chronic Obstructive Pulmonary Disease	22
Diabetes	32
Dementia	15
Cancer	48

Medicare Procedure and Patient Information

2019 Medicare Procedure Volume

The top procedures that Dr. Matthew Burns Cotant, MD treated as a medical oncologist in Royal Oak, MI during 2019 were lab tests, blood draw, minimally invasive procedures and hospital care.

Volume of procedures performed by Dr. Matthew Burns Cotant, MD for Medicare patients.

biological response modifier (BRM) therapy	462
blood draw	1938
chemotherapy	462
doctor visit	1799
hormone therapy	19
hospital care	491
inpatient care	491
lab tests	5132
minimally invasive procedures	549
preventive care	15
vaccines	15

2019 Medicare Patient Data

Information about Medicare patients treated by Dr. Matthew Burns Cotant, MD.

**Gender**
Male	321
Female	394

**Ethnicity**
Non-Hispanic White	599
Black	79
Hispanic	0
Asian	0
Other	18
Native American	0

**Age**
From 65 to 74	305
From 75 to 84	245
85 and over	110
Less than 65	55

Conditions of Medicare patients treated by Dr. Matthew Burns Cotant, MD in 2019

Hypertension	75
High Cholesterol	66
Stroke	11
Ischemic Heart Disease	47
Depression	28
Chronic Kidney Disease	53
Asthma	10
Osteoperosis	15
Atrial Fibrilation	17
Heart Failure	27
Chronic Obstructive Pulmonary Disease	22
Diabetes	32
Dementia	14
Cancer	47

Medicare Procedure and Patient Information

2020 Medicare Procedure Volume

The top procedures that Dr. Matthew Burns Cotant, MD treated as a medical oncologist in Royal Oak, MI during 2020 were lab tests, blood draw, minimally invasive procedures and hospital care.

Volume of procedures performed by Dr. Matthew Burns Cotant, MD for Medicare patients.

biological response modifier (BRM) therapy	384
blood draw	1560
chemotherapy	384
doctor visit	1466
hormone therapy	27
hospital care	422
inpatient care	422
lab tests	3812
minimally invasive procedures	425
preventive care	20
vaccines	20

2020 Medicare Patient Data

Information about Medicare patients treated by Dr. Matthew Burns Cotant, MD.

**Gender**
Male	268
Female	323

**Ethnicity**
Non-Hispanic White	513
Black	49
Hispanic	0
Asian	0
Other	16
Native American	0

**Age**
From 65 to 74	253
From 75 to 84	220
85 and over	83
Less than 65	35

Conditions of Medicare patients treated by Dr. Matthew Burns Cotant, MD in 2020

Hypertension	75
High Cholesterol	66
Stroke	10
Ischemic Heart Disease	49
Depression	27
Chronic Kidney Disease	54
Asthma	11
Osteoperosis	12
Atrial Fibrilation	18
Heart Failure	29
Chronic Obstructive Pulmonary Disease	19
Diabetes	32
Dementia	16
Cancer	45

Medicare Procedure and Patient Information

2021 Medicare Procedure Volume

The top procedures that Dr. Matthew Burns Cotant, MD treated as a medical oncologist in Royal Oak, MI during 2021 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Matthew Burns Cotant, MD for Medicare patients.

biological response modifier (BRM) therapy	489
blood draw	1880
chemotherapy	489
doctor visit	1695
hormone therapy	53
hospital care	282
inpatient care	282
lab tests	5285
minimally invasive procedures	539
port flush	14

2021 Medicare Patient Data

Information about Medicare patients treated by Dr. Matthew Burns Cotant, MD.

**Gender**
Male	273
Female	340

**Ethnicity**
Non-Hispanic White	524
Black	61
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	267
From 75 to 84	228
85 and over	87
Less than 65	31

Conditions of Medicare patients treated by Dr. Matthew Burns Cotant, MD in 2021

Hypertension	75
High Cholesterol	67
Stroke	9
Ischemic Heart Disease	49
Depression	27
Chronic Kidney Disease	49
Asthma	13
Osteoperosis	14
Atrial Fibrilation	15
Heart Failure	27
Chronic Obstructive Pulmonary Disease	19
Diabetes	32
Dementia	15
Cancer	47

Medicare Procedure and Patient Information

2022 Medicare Procedure Volume

The top procedures that Dr. Matthew Burns Cotant, MD treated as a medical oncologist in Royal Oak, MI during 2022 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Matthew Burns Cotant, MD for Medicare patients.

biological response modifier (BRM) therapy	396
blood draw	1699
chemotherapy	396
doctor visit	1581
hormone therapy	33
hospital care	380
inpatient care	380
lab tests	4584
minimally invasive procedures	499
port flush	18

2022 Medicare Patient Data

Information about Medicare patients treated by Dr. Matthew Burns Cotant, MD.

**Gender**
Male	305
Female	378

**Ethnicity**
Non-Hispanic White	596
Black	56
Hispanic	0
Asian	0
Other	18
Native American	0

**Age**
From 65 to 74	276
From 75 to 84	274
85 and over	97
Less than 65	36

Conditions of Medicare patients treated by Dr. Matthew Burns Cotant, MD in 2022

Hypertension	75
High Cholesterol	75
Stroke	15
Ischemic Heart Disease	38
Depression	24
Chronic Kidney Disease	35
Asthma	14
Osteoperosis	18
Atrial Fibrilation	27
Heart Failure	26
Chronic Obstructive Pulmonary Disease	24
Diabetes	29
Dementia	9
Cancer	51

Medicare Procedure and Patient Information

Average Medicare Procedure Volume From 2012 - 2022

Volume of procedures performed by Dr. Matthew Burns Cotant, MD for Medicare patients.

The highest averages for the top procedures that Dr. Matthew Burns Cotant, MD treated as a medical oncologist in Royal Oak, MI were lab tests, blood draw, hospital care and inpatient care.

biological response modifier (BRM) therapy	408
blood draw	1710
chemotherapy	408
doctor visit	1633
hormone therapy	41
hospital care	511
inpatient care	511
lab tests	4261
minimally invasive procedures	492
preventive care	22
vaccines	22

Average Medicare Patient Data From 2012 - 2022

Information about Medicare patients treated by Dr. Matthew Burns Cotant, MD.

**Gender**
Male	304
Female	401

**Ethnicity**
Black / African American	67
Asian / Pacific Islander	1
Non-Hispanic White	606
Native American / Alaskan Native	0
Hispanic	0
Other	11

**Age**
75 to 84	252
85 and over	115
Less than 65	51
65 to 74	285

Average of Total of Conditions of Medicare patients treated by Dr. Matthew Burns Cotant, MD From 2012 - 2022

The highest averages of the most common conditions of Medicare patients that Dr. Matthew Burns Cotant, MD treated were hypertension, high cholesterol, chronic kidney disease and ischemic heart disease.

Hypertension	67
High Cholesterol	56
Stroke	8
Ischemic Heart Disease	42
Depression	21
Chronic Kidney Disease	42
Asthma	11
Osteoporosis	11
Heart Failure	25
Chronic Obstructive Pulmonary Disease	19
Diabetes	29
Atrial Fibrillation	16
Dementia	11
Cancer	41

Education & Training

Dr. Matthew Burns Cotant, MD graduated from Wayne State University School of Medicine. He completed residency at Henry Ford Hospital. He is certified by the Medical Oncology, American Board of Internal Medicine and has a state license in Michigan.

Medical School: Wayne State University School of Medicine

Residency: Henry Ford Hospital

Board Certification: Medical Oncology, American Board of Internal Medicine

Licensed In: Michigan

Affiliations & Hospitals

Dr. Matthew Burns Cotant, MD is associated with these hospitals and organizations:

Trinity Health

McLaren Health Care

Michigan Healthcare Professionals

Insurance Information

Please note: Insurance information may change at any time, and the provider may accept your insurance plan even if it is not listed below. Please contact the provider's office to confirm that your insurance is accepted.

Dr. Matthew Burns Cotant, MD appears to accept the following insurance providers: Colleague Health Plan.

Insurance Accepted by Provider includes:

According to our sources, Dr. Matthew Burns Cotant, MD accepts the following insurance providers:

Colleague Health Plan

Ratings & Reviews

Dr. Matthew Burns Cotant, MD does not have any reviews yet, be the first to leave a review of Dr. Matthew Burns Cotant, MD here: Leave a Review

(No ratings)

Leave a Review

General Payments

These charts describe general payments received by Dr. Matthew Burns Cotant, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.

**Payments by Company**
Genentech USA, Inc.	$1,809 TECENTRIQ $330	Avastin $259	Kadcyla $250	TARCEVA $191	Gazyva $142	Other $638
Novartis Pharmaceuticals Corporation	$1,163 PROMACTA $209	TASIGNA $189	AFINITOR $150	KISQALI $108	TAFINLAR $81	Other $425
Amgen Inc.	$1,155 Kyprolis $261	Vectibix $227	XGEVA $223	Prolia $93	Blincyto $70	Other $281
E.R. Squibb & Sons, L.L.C.	$917 OPDIVO $646	SPRYCEL $84	ERBITUX $63	EMPLICITI $54	OPDUALAG $30	Other $40
AstraZeneca Pharmaceuticals LP	$857 IMFINZI $329	TAGRISSO $165	LYNPARZA $135	CALQUENCE $107	FASLODEX $52	Other $69
Other	$9,411 JEVTANA $580	XTANDI $404	KEYTRUDA $381	Lenvima $309	DARZALEX $237	Other $7,500

**Types of Payments**
Food and Beverage	$12,950
Education	$2,090
Consulting Fee	$200
Gift	$74

Research Payments

Dr. Matthew Burns Cotant, MD has received 6 research payments totaling $3,514.

Biography

Dr. Matthew Cotant is an adult hematology, adult oncology, and medical oncology specialist in Royal Oak, MI, Troy, MI, and Clarkston, MI. His areas of clinical interest consist of cancer and blood disorders. Dr. Cotant is professionally affiliated with Michigan Healthcare Professionals, McLaren Health Care, and Trinity Health. After attending Wayne State University School of Medicine, he completed his residency training at Henry Ford Hospital. According to Trinity Health, new patients are welcome to contact Dr. Cotant's office in Royal Oak, MI.